Showing results (221-230 of 4,238) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|March 10, 2022
Necroptosis-driving genes RIPK1, RIPK3 and MLKL-p are associated with intratumoral CD3+ and CD8+ T cell density and predict prognosis in hepatocellular carcinomaLorenzo Nicolè, Tiziana Sanavia, Rocco Cappellesso, et al.Journal for Immunotherapy of Cancer|March 10, 2022
Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapyKatie M Campbell, Maneesha Thaker, Egmidio Medina, et al.Journal for Immunotherapy of Cancer|March 4, 2022
Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancerYuezong Bai, Tong Xie, Zhenghang Wang, et al.Journal for Immunotherapy of Cancer|June 15, 2018
Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatmentLéa Paolini, Caroline Poli, Simon Blanchard, et al.Journal for Immunotherapy of Cancer|May 2, 2018
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054Yiwen Li, Carmine Carpenito, George Wang, et al.Journal for Immunotherapy of Cancer|September 3, 2025
Preclinical evaluation of antitumor activity and toxicity of TROP2-specific CAR-T cells for treatment of triple-negative breast cancerShiyu Sun, Xiaojia Wang, Yongchen Chen, et al.Journal for Immunotherapy of Cancer|September 5, 2025
Differential phagocytosis induces diverse macrophage activation states in malignant gliomasSenthilnath Lakshmanachetty, Kent Riemondy, Bridget Sanford, et al.Journal for Immunotherapy of Cancer|September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapyBenjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.Journal for Immunotherapy of Cancer|June 3, 2017
Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancerSotirios P Fortis, Michael Sofopoulos, Nectaria N Sotiriadou, et al.Journal for Immunotherapy of Cancer|May 19, 2017
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapySacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, et al.Pageof 424